Figure 3From: Pitavastatin in cardiometabolic disease: therapeutic profilePitavastatin induced greater plaque volume reduction by high-density lipoprotein cholesterol unit increase. Compared with other statins, pitavastatin is associated with the greatest reduction in plague volume per 1% increase in high-density lipoprotein-cholesterol (HDL-C) (KISHIMEN study). Adapted from [37].Back to article page